Drugs.com - Clinical Trials

Repurposing Blood Pressure Drug Reserpine May Prevent Vision Loss in Inherited Blinding Diseases

Tuesday, April 15, 2025 -- New studies in rats suggest the drug reserpine, approved in 1955 for high blood pressure, might treat the blinding disease retinitis pigmentosa. No therapy exists for this rare inherited disease, which starts affecting...

Apr 15, 2025 - 22:15
 0
Repurposing Blood Pressure Drug Reserpine May Prevent Vision Loss in Inherited Blinding Diseases
Tuesday, April 15, 2025 -- New studies in rats suggest the drug reserpine, approved in 1955 for high blood pressure, might treat the blinding disease retinitis pigmentosa. No therapy exists for this rare inherited disease, which starts affecting...
Read More

Tags:

Previous Article

United Airlines Cuts Domestic Flights but Sees Uptick in International and Premi...

Next Article

American Airlines’ Free In-Flight Wi-Fi Coming Next Year

Related Posts

Eneboparatide Met Primary Endpoint of Normalising Serum Calcium in Adults with Hypoparathyroidism at 24 weeks in CALYPSO Phase III Trial

Eneboparatide Met Primary Endpoint of Normalising Serum...

Mar 17, 2025  0

Novo Nordisk Warns Consumers About Counterfeit Ozempic (semaglutide) Injection 1 mg in the US

Novo Nordisk Warns Consumers About Counterfeit Ozempic ...

Apr 15, 2025  0

Incyte Announces Positive Topline Results From Two Phase 3 Clinical Trials of Povorcitinib in Patients With Hidradenitis Suppurativa

Incyte Announces Positive Topline Results From Two Phas...

Mar 18, 2025  0